Comparison of seven staging systems in cirrhotic patients with hepatocellular carcinoma in a cohort of patients who underwent radiofrequency ablation with complete response

American Journal of Gastroenterology

Volumn 103, Issue 3, 2008, Pages 597-604

  Guglielmi, Alfredo ^a   Ruzzenente, Andrea ^a   Pachera, Silvia ^a   Valdegamberi, Alessandro ^a   Sandri, Marco ^b   D'Onofrio, Mirko ^a   Iacono, Calogero ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; COHORT ANALYSIS; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; LINEAR SYSTEM; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; SCORING SYSTEM; SURVIVAL RATE; SURVIVAL TIME; TREATMENT RESPONSE; UNIVARIATE ANALYSIS;

AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 40949127006     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01604.x     Document Type: Article

References (31)

1. Bosch FX, Ribes J, Cleries R, et al. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2005 191 211.
2. Befeler AS, Di Bisceglie AM. Hepatocellular carcinoma: Diagnosis and treatment. Gastroenterology 2002 122 : 1609 19.
3. Vivarelli M, Guglielmi A, Ruzzenente A, et al. Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg 2004 240 : 102 7.
4. Trevisani F, D'Intino PE, Morselli-Labate AM, et al. Serum alphafetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: Influence of HBsAg and anti-HCV status. J Hepatol 2001 34 : 570 5.
5. Ryder S. Predicting survival in early hepatocellular carcinoma. Gut 2005 54 : 328 9.
6. Wildi S, Pestalozzi BC, McCormack L, et al. Critical evaluation of the different staging systems for hepatocellular carcinoma. Br J Surg 2004 91 : 400 8.
7. Burns JM, Greene FL. Controversies in staging of hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2005 12 : 456 62.
8. Okuda K, Ohtsuki T, Obata H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: Study of 850 patients. Cancer 1985 56 : 918 28.
9. The Cancer of the Liver Italian Program (CLIP) investigators. A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients. Hepatology 1998 28 : 751 5.
10. Bruix J, Sherman M, Llovet JM, et al. EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001 35 : 421 30.
11. Chevret S, Trinchet JC, Mathieu D, et al. A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. J Hepatol 1999 31 : 133 41.
12. Leung TWT, Tang AMY, Zee B, et al. Construction of the Chinese university prognostic index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program Staging System: A study based on 926 patients. Cancer 2002 94 : 1760 9.
13. Kudo M, Chung H, Osaki Y. Prognostic staging system for hepatocellular carcinoma (CLIP score): Its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol 2003 38 : 207 15.
14. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: The BCLC staging classification. Semin Liver Dis 1999 19 : 329 38.
15. Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer 1981 47 : 207 14.
16. Ueno S, Tanabe G, Sako K, et al. Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of the Liver Italian Program. Hepatology 2001 34 : 529 34.
17. Greene FL, Page DL, Fleminig DL, et al. eds. Liver including intrahepatic bile ducts. American Joint Committee on Cancer Staging Manual, 6th Ed. New York : Springer, 2002 : 145 53.
18. Ramacciato G, Mercantini P, Cautero N, et al. Prognostic evaluation of the new American Joint Committee on Cancer/International Union Against Cancer staging system for hepatocellular carcinoma: Analysis of 112 cirrhotic patients resected for hepatocellular carcinoma. Ann Surg Oncol 2005 12 : 289 97. Epub 2005 March 14.
19. Varotti G, Ramacciato G, Ercolani G, et al. Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: Multicentric study on 393 cirrhotic resected patients. Eur J Surg Oncol 2005 31 : 760 7.
20. Levy I, Sherman M. Staging of hepatocellular carcinoma: Assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto. Gut 2002 50 : 881 5.
21. Farinati F, Rinaldi M, Gianni S, et al. How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system. Cancer 2000 89 : 2266 73.
22. Zhao WH, Ma ZM, Zhou XR, et al. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score. World J Gastroenterol 2002 8 : 237 42.
23. Llovet JM. Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 2005 40 : 225 35.
24. Cillo U, Bassanello M, Vitale A, et al. The critical issue of hepatocellular carcinoma prognostic classification: Which is the best tool available? J Hepatol 2004 40 : 124 31.
25. Grieco A, Pompili Caminiti G, Miele L, et al. Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing nonsurgical therapy: Comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. Gut 2005 54 : 411 8.
26. Marrero JA, Fontana RJ, Barrat A, et al. Prognosis of hepatocellular carcinoma: Comparison of 7 staging systems in an american cohort. Hepatology 2005 41 : 707 16.
27. Sala M, Forner A, Varela M, et al. Prognostic prediction in patients with hepatocellular carcinoma. Semin Liver Dis 2005 25 : 171 80.
28. Kudo M, Chung H, Haji S, et al. Validation of a new prognostic staging system for hepatocellular carcinoma: The JIS score compared with the CLIP score. Hepatology 2004 40 : 1396 405.
29. Giannini E, Risso D, Botta F, et al. Prognosis of hepatocellular carcinoma in anti-HCV positive cirrhotic patients: A single-centre comparison amongst four different staging systems. J Intern Med 2004 255 : 399 408.
30. Guglielmi A, Ruzzenente A, Sandri M, et al. Radiofrequency ablation for HCC in cirrhotic patients: Prognostic factors for survival. J Gastrointest Surg 2007 11 : 143 9.
31. Toyoda H, Kumada T, Kiriyama S, et al. Comparison of the usefulness of three staging systems for hepatocellular carcinoma (CLIP, BCLC, and JIS) in Japan. Am J Gastroenterol 2005 100 : 1764 71.